Horseracing’s Welfare and Integrity Unit, established by Drug Free Sport International to administer the Integrity and Safety Authority’s Drug Control and Anti-Doping and Safety Program, announced on October 4 that they appointed Dr. Mary Scollay as their scientific director.
In this role, beginning October 10, Scollay will oversee HIWU’s Science Department, including the HISA Equine Analysis Laboratory accreditation program, and pre-launch education efforts. ADMC in January 2023. She will also prioritize research development into Prohibited Substances while interacting with veterinary scientists, pharmacists, and other Purebred industry experts. Additionally, Scollay and her team will manage a database of Prohibited Substances that will be available for use as a reference tool by industry stakeholders.
Scollay joins HIWU after serving as chief executive officer and chief executive officer of the Racing Medication & Testing Consortium for three years. During her time with the RMTC, she directed the improvement of world-class laboratory drug testing standards, promoting the rules and penalties recommended by the RMTC for banned substances and drugs. treatment, monitoring of emerging threats to race integrity and the health and welfare of racehorses, and administrative oversight of research projects and educational programs funded by the RMTC aid.
Prior to leading the RMTC, Scollay spent more than 30 years as a veterinarian on the racing governing body, including 11 years as medical director of the Kentucky Equestrian Commission.
Ben Mosier, chief executive officer of HIWU said: “Dr. Scollay’s extensive experience in the areas of anti-doping regulation, testing standards and veterinary regulation in the Purebred industry will make her a talent. HIWU’s main product,” said Ben Mosier, chief executive officer of HIWU. “We are fortunate to retain her knowledge and skills as we prepare for the implementation of the ADMC Program on January 1, 2023.”
Appointed to HISA’s ADMC Standing Committee in May 2021, Scollay relinquished that responsibility to take up his position at HIWU.
“HISA represents the way forward for Thoroughbred racing, the only way forward,” said Scollay. “I am grateful for the opportunity to continue serving the sport during this transition, and I am committed to working with HIWU to provide the best equine anti-doping program in the industry.”
The ADMC program will create a centralized inspection and results management process, and effectively and consistently apply uniform penalties for violations across all equestrian jurisdictions. Purebred American that HISA administers. HIWU will oversee testing, educate stakeholders about the new program, accredit laboratories, investigate potential violations, and prosecute any such violations.
HISA was created when the Equestrian Safety and Integrity Act was signed into federal law by President Donald Trump in 2020 and is responsible for drafting and enforcing uniform safety rules, regulations Anti-Doping and Drug Control Rules in Purebred Racing in the U.S. Oversaw by the Federal Trade Commission, HISA was established to implement, for the first time, a unified, nationally applicable set of rules. available to everyone participating in Purebred races and track facilities. HISA consists of two programs: the Track Safety Program, effective July 1; and the ADMC Program, effective January 1.
Drug Free Sport International administers comprehensive drug testing programs, manages national and international collections, develops drug testing policies, and provides educational services to a variety of athletics organizations. Professionals and amateurs around the world.
This press release has been edited for content and style by the BloodHorse Staff.
